Biologic therapy for psoriasis is associated with reduced risk of death: Insights from the VA clinical assessment, reporting and tracking program
J Eur Acad Dermatol Venereol
.
2023 Jul;37(7):e862-e864.
doi: 10.1111/jdv.18964.
Epub 2023 Feb 27.
Authors
Taufiq Salahuddin
1
,
Annika Hebbe
2
3
,
Christopher P Kovach
1
4
,
Aaron Strobel
4
,
Ehrin J Armstrong
5
,
Stephen W Waldo
2
3
4
Affiliations
1
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
2
Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.
3
CART Program, Office of Quality and Patient Safety, Veterans Health Administration, Washington, District of Columbia, USA.
4
Division of Cardiology, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
5
Adventist Heart and Vascular Institute, St. Helena, California, USA.
PMID:
36786354
DOI:
10.1111/jdv.18964
No abstract available
Publication types
Letter
MeSH terms
Biological Products* / therapeutic use
Biological Therapy
Humans
Psoriasis* / drug therapy
Substances
Biological Products